{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:48Z","timestamp":1789981308481,"version":"4.0.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s00210-026-05588-z","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T04:01:25Z","timestamp":1781841685000},"page":"19105-19116","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of baloxavir marboxil vs. oseltamivir in Chinese outpatients with influenza B: an IPTW-adjusted real-world cohort study"],"prefix":"10.1007","volume":"399","author":[{"given":"Zhixiang","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoli","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,19]]},"reference":[{"key":"5588_CR1","doi-asserted-by":"publisher","first-page":"1467029","DOI":"10.3389\/fmicb.2024.1467029","volume":"15","author":"MA Ashraf","year":"2024","unstructured":"Ashraf MA, Raza MA, Amjad MN, Ud Din G, Yue L, Shen B, Chen L, Dong W, Xu H, Hu Y (2024) A comprehensive review of influenza B virus, its biological and clinical aspects. Front Microbiol 15:1467029","journal-title":"Front Microbiol"},{"issue":"9","key":"5588_CR2","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1080\/14656566.2024.2370895","volume":"25","author":"M Bassetti","year":"2024","unstructured":"Bassetti M, Sepulcri C, Giacobbe DR, Fusco L (2024) Treating influenza with neuraminidase inhibitors: an update of the literature. Expert Opin Pharmacother 25(9):1163\u20131174","journal-title":"Expert Opin Pharmacother"},{"key":"5588_CR3","doi-asserted-by":"publisher","first-page":"1428095","DOI":"10.3389\/fmicb.2024.1428095","volume":"15","author":"J Cai","year":"2024","unstructured":"Cai J, Wang H, Ye X, Lu S, Tan Z, Li Z, Lin D, Qian J, Lu X, Wan J, Wang J, Ai J, Pu Y, Qu L, Wang S (2024) Real-world effectiveness and safety of Baloxavir Marboxil or Oseltamivir in outpatients with uncomplicated influenza A: an ambispective, observational, multi-center study. Front Microbiol 15:1428095","journal-title":"Front Microbiol"},{"issue":"1","key":"5588_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/cimb46010014","volume":"46","author":"GU Din","year":"2023","unstructured":"Din GU, Hasham K, Amjad MN, Hu Y (2023) Natural history of influenza B virus-current knowledge on treatment, resistance and therapeutic options. Curr Issues Mol Biol 46(1):183\u2013199","journal-title":"Curr Issues Mol Biol"},{"issue":"10454","key":"5588_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/S0140-6736(24)01307-2","volume":"404","author":"Y Gao","year":"2024","unstructured":"Gao Y, Guyatt G, Uyeki TM, Liu M, Chen Y, Zhao Y, Shen Y, Xu J, Zheng Q, Li Z, Zhao W, Luo S, Chen X, Tian J, Hao Q (2024) Antivirals for treatment of severe influenza: a systematic review and network meta-analysis of randomised controlled trials. Lancet (London, England) 404(10454):753\u2013763","journal-title":"Lancet (London, England)"},{"key":"5588_CR6","doi-asserted-by":"publisher","first-page":"1418321","DOI":"10.3389\/fped.2024.1418321","volume":"12","author":"X Ge","year":"2024","unstructured":"Ge X, Chen Y, Wu W, Lu J, Wang Y, Li Z (2024) Safety and effectiveness of baloxavir marboxil and oseltamivir for influenza in children: a real-world retrospective study in China. Front Pediatr 12:1418321","journal-title":"Front Pediatr"},{"issue":"10","key":"5588_CR7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1080\/14656566.2024.2376660","volume":"25","author":"C Gu","year":"2024","unstructured":"Gu C, Chen Y, Li H, Wang J, Liu S (2024) Considerations when treating influenza infections with oseltamivir. Expert Opin Pharmacother 25(10):1301\u20131316","journal-title":"Expert Opin Pharmacother"},{"key":"5588_CR8","doi-asserted-by":"publisher","first-page":"107051","DOI":"10.1016\/j.micpath.2024.107051","volume":"197","author":"J Han","year":"2024","unstructured":"Han J, Yang C, Xiao Y, Li J, Jin N, Li Y (2024) Influenza B virus: Target and acting mechanism of antiviral drugs. Microb Pathog 197:107051","journal-title":"Microb Pathog"},{"issue":"2","key":"5588_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.amjms.2025.10.010","volume":"371","author":"A Hannaford","year":"2026","unstructured":"Hannaford A, Aleissa M, Sherman AC (2026) Update on influenza. Am J Med Sci 371(2):124\u2013132","journal-title":"Am J Med Sci"},{"issue":"1","key":"5588_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1001\/jamainternmed.2023.0699","volume":"184","author":"R Hanula","year":"2024","unstructured":"Hanula R, Bortolussi-Courval \u00c9, Mendel A, Ward BJ, Lee TC, McDonald EG (2024) Evaluation of oseltamivir used to prevent hospitalization in outpatients with influenza: a systematic review and meta-analysis. JAMA Intern Med 184(1):18\u201327","journal-title":"JAMA Intern Med"},{"issue":"10","key":"5588_CR11","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, Ishida T, Sekino H, Yamada K, Portsmouth S, Kawaguchi K, Shishido T, Arai M, Tsuchiya K, Uehara T, Watanabe A (2018) Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med 379(10):913\u2013923","journal-title":"N Engl J Med"},{"issue":"4","key":"5588_CR12","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s40121-025-01131-4","volume":"14","author":"N Ishiguro","year":"2025","unstructured":"Ishiguro N, Morioka I, Nakano T, Manabe A, Kawaguchi K, Tanaka S, Kinoshita M (2025) Clinical and virologic outcomes of baloxavir compared with oseltamivir in pediatric patients with influenza in Japan. Infect Dis Ther 14(4):833\u2013846","journal-title":"Infect Dis Ther"},{"issue":"10","key":"5588_CR13","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S1473-3099(20)30004-9","volume":"20","author":"MG Ison","year":"2020","unstructured":"Ison MG, Portsmouth S, Yoshida Y, Shishido T, Mitchener M, Tsuchiya K, Uehara T, Hayden FG (2020) Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial. Lancet Infect Dis 20(10):1204\u20131214","journal-title":"Lancet Infect Dis"},{"key":"5588_CR14","doi-asserted-by":"publisher","first-page":"107671","DOI":"10.1016\/j.micpath.2025.107671","volume":"205","author":"R Jain","year":"2025","unstructured":"Jain R, Sharma H, Pena L, Jit S, Rathi B, De Oliveira RN, Verma M (2025) Influenza virus: Genomic insights, evolution, and its clinical presentation. Microb Pathog 205:107671","journal-title":"Microb Pathog"},{"issue":"3","key":"5588_CR15","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/03610920500476671","volume":"35","author":"YH Joshua Chen","year":"2006","unstructured":"Joshua Chen YH, Frank Liu GH (2006) A note on the estimate of treatment effect from a Cox regression model when the proportionality assumption is violated. J Commun Stat 35(3):521\u2013526","journal-title":"J Commun Stat"},{"issue":"1","key":"5588_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","volume":"4","author":"F Krammer","year":"2018","unstructured":"Krammer F, Smith GJD, Fouchier RAM, Peiris M, Kedzierska K, Doherty PC, Palese P, Shaw ML, Treanor J, Webster RG, Garc\u00eda-Sastre A (2018) Influenza. Nat Rev Dis Prim 4(1):3","journal-title":"Nat Rev Dis Prim"},{"issue":"5","key":"5588_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jmii.2021.04.002","volume":"54","author":"YC Kuo","year":"2021","unstructured":"Kuo YC, Lai CC, Wang YH, Chen CH, Wang CY (2021) Clinical efficacy and safety of baloxavir marboxil in the treatment of influenza: A systematic review and meta-analysis of randomized controlled trials. J Microbiol Immunol Infect = Wei Mian Yu Gan Ran Za Zhi 54(5):865\u2013875","journal-title":"J Microbiol Immunol Infect = Wei Mian Yu Gan Ran Za Zhi"},{"key":"5588_CR18","unstructured":"listed Na (2006) Baloxavir. Drugs and lactation database (LactMed\u00ae). National Institute of Child Health and Human Development, Bethesda (MD)"},{"key":"5588_CR19","doi-asserted-by":"crossref","unstructured":"Nezu K, Hayashida S, Nagano N, Udagawa S, Morioka I (2023) Early fever resolution in early childhood influenza treated with baloxavir marboxil: a retrospective study compared to those with oseltamivir. Medicina (Kaunas, Lithuania) 59(9)","DOI":"10.3390\/medicina59091543"},{"issue":"1","key":"5588_CR20","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12874-017-0338-0","volume":"17","author":"TL Nguyen","year":"2017","unstructured":"Nguyen TL, Collins GS, Spence J, Daur\u00e8s JP, Devereaux PJ, Landais P, Le Manach Y (2017) Double-adjustment in propensity score matching analysis: choosing a threshold for considering residual imbalance. BMC Med Res Methodol 17(1):78","journal-title":"BMC Med Res Methodol"},{"key":"5588_CR21","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coviro.2019.01.006","volume":"35","author":"R O'Hanlon","year":"2019","unstructured":"O\u2019Hanlon R, Shaw ML (2019) Baloxavir marboxil: the new influenza drug on the market. Curr Opin Virol 35:14\u201318","journal-title":"Curr Opin Virol"},{"issue":"3","key":"5588_CR22","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.jiac.2023.10.017","volume":"30","author":"C Shiraishi","year":"2024","unstructured":"Shiraishi C, Kato H, Hagihara M, Asai N, Iwamoto T, Mikamo H (2024) Comparison of clinical efficacy and safety of baloxavir marboxil versus oseltamivir as the treatment for influenza virus infections: A systematic review and meta-analysis. J Infect Chemother Off J Japan Soc Chemother 30(3):242\u2013249","journal-title":"J Infect Chemother Off J Japan Soc Chemother"},{"issue":"9","key":"5588_CR23","doi-asserted-by":"publisher","DOI":"10.1111\/irv.70002","volume":"18","author":"T Takazono","year":"2024","unstructured":"Takazono T, Ito G, Hosogaya N, Iwanaga N, Komeda T, Kobayashi M, Kitanishi Y, Ogura E, Mukae H (2024) Comparison of the effectiveness of baloxavir and oseltamivir in outpatients with influenza B. Influenza Other Respir Viruses 18(9):e70002","journal-title":"Influenza Other Respir Viruses"},{"issue":"10353","key":"5588_CR24","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0140-6736(22)00982-5","volume":"400","author":"TM Uyeki","year":"2022","unstructured":"Uyeki TM, Hui DS, Zambon M, Wentworth DE, Monto AS (2022) Influenza. Lancet (London, England) 400(10353):693\u2013706","journal-title":"Lancet (London, England)"},{"key":"5588_CR25","doi-asserted-by":"publisher","first-page":"105310","DOI":"10.1016\/j.antiviral.2022.105310","volume":"201","author":"K Wagatsuma","year":"2022","unstructured":"Wagatsuma K, Saito R, Chon I, Phyu WW, Fujio K, Kawashima T, Sato I, Saito T, Minato M, Kodo N, Suzuki E, Ono Y, Masaki H, Shirahige Y, Kitano A, Hamabata H, Yuyang S, Jiaming L, Watanabe H (2022) Duration of fever and symptoms in influenza-infected children treated with baloxavir marboxil during the 2019\u20132020 season in Japan and detection of influenza virus with the PA E23K substitution. Antiviral Res 201:105310","journal-title":"Antiviral Res"},{"issue":"36","key":"5588_CR26","doi-asserted-by":"publisher","first-page":"905","DOI":"10.46234\/ccdcw2024.069","volume":"6","author":"Y Xie","year":"2024","unstructured":"Xie Y, Lin S, Zeng X, Tang J, Cheng Y, Huang W, Li J, Wang D (2024) Two peaks of seasonal influenza epidemics \u2013 China, 2023. China CDC Weekly 6(36):905\u2013910","journal-title":"China CDC Weekly"},{"issue":"1","key":"5588_CR27","doi-asserted-by":"publisher","first-page":"2429627","DOI":"10.1080\/22221751.2024.2429627","volume":"13","author":"J Xu","year":"2024","unstructured":"Xu J, Luo Q, Huang Y, Li J, Ye W, Yan R, Zhou X, He Z, Liu G, Zhu Q (2024) Influenza neuraminidase mutations and resistance to neuraminidase inhibitors. Emerg Microbes Infect 13(1):2429627","journal-title":"Emerg Microbes Infect"},{"issue":"3","key":"5588_CR28","doi-asserted-by":"publisher","first-page":"196","DOI":"10.2174\/0113895575316416240724043949","volume":"25","author":"J Yong","year":"2025","unstructured":"Yong J, Lu S, Lu C, Huang R (2025) The development history, structural composition, and functions of influenza viruses and the progress of influenza virus inhibitors in clinics and clinical trials. Mini Rev Med Chem 25(3):196\u2013207","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"5588_CR29","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1038\/s41598-023-33726-7","volume":"13","author":"AQ Zhu","year":"2023","unstructured":"Zhu AQ, Li ZJ, Zhang HJ (2023) Spatial timing of circulating seasonal influenza A and B viruses in China from 2014 to 2018. Sci Rep 13(1):7149","journal-title":"Sci Rep"},{"issue":"6","key":"5588_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0326777","volume":"20","author":"L Zhu","year":"2025","unstructured":"Zhu L, Zhong L, Huang G (2025) Clinical efficacy and Safety of Baloxavir Marboxil compared with Oseltamivir against influenza virus in children: A systematic review and meta-analysis. PLoS ONE 20(6):e0326777","journal-title":"PLoS ONE"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05588-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05588-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05588-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:14:34Z","timestamp":1789978474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05588-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["5588"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05588-z","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"30 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was reviewed and approved by the Ethics Committee of Shanghai Fourth People\u2019s Hospital (Approval No. 2024059\u2013001). The requirement for informed consent was waived as the study was determined to be retrospective, observational, and did not involve virus tracing or human genetic resources.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent to publish","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}